Laboratorios Richmond S.A.C.I.F.
RICH
Rank in Stocks
#21131
Laboratorios Richmond S.A.C.I.F. is a pharmaceutical firm focused on the... Laboratorios Richmond S.A.C.I.F. is a pharmaceutical firm focused on the development and production of a diverse range of medicinal products. Their extensive portfolio includes antiretroviral treatments for human immunodeficiency virus (HIV), as well as therapies for oncology and oncohematology conditions. The company also supplies various cardiometabolic medications, such as those for blood pressure reduction, cholesterol management, platelet aggregation inhibition, and blood sugar control. Additionally, they produce neurological and psychiatric drugs, covering analgesics, antipsychotics, antidepressants, anti-dementia agents, antiepileptics, hypnotics, and treatments for multiple sclerosis. These pharmaceutical offerings are distributed across Latin America, Africa, Asia, and the Middle East. Founded in 1935, Laboratorios Richmond S.A.C.I.F. is headquartered in Buenos Aires, Argentina.
Share Price
$0.90251515
Last synced: 2026-11-06
Market Cap
$72.88M
Change (1 day)
7.43%
Change (1 year)
-20.46%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Laboratorios Richmond S.A.C.I.F. (RICH)
Category
Healthcare
Operating Margin for Laboratorios Richmond S.A.C.I.F. (RICH)
Operating Margin as of November 2026 TTM: 17.67%
According to Laboratorios Richmond S.A.C.I.F.'s latest financial reports, its current operating margin (TTM) is 17.67%. At the end of 2025 the company had an operating margin of 23.60%.
Operating Margin history for Laboratorios Richmond S.A.C.I.F. from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 17.67% | -25.13% |
| 2025 | 23.60% | 37.93% |
| 2024 | 17.11% | 31.21% |
| 2023 | 13.04% | -18.86% |
| 2022 | 16.07% | 15.78% |
| 2021 | 13.88% | -48.34% |
| 2020 | 26.87% | 34.08% |
| 2019 | 20.04% | 174.52% |
| 2018 | 7.30% | -44.19% |
| 2017 | 13.08% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.90% |
DE
|
|
| 19.68% | -98.89% |
DE
|
|
| 13.26% | -99.25% |
JP
|
|
| 17.08% | -99.03% |
CH
|
|
| 14.92% | -99.16% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Laboratorios Richmond S.A.C.I.F.'s operating margin
What is Laboratorios Richmond S.A.C.I.F.'s operating margin?
Laboratorios Richmond S.A.C.I.F.'s operating margin is 17.67%, as of Nov 2026.
What was Laboratorios Richmond S.A.C.I.F.'s operating margin in 2025?
In 2025, Laboratorios Richmond S.A.C.I.F.'s operating margin was 23.60%, compared with 17.11% in 2024.
How has Laboratorios Richmond S.A.C.I.F.'s operating margin changed since 2020?
From 2020 to 2025, Laboratorios Richmond S.A.C.I.F.'s operating margin was highest in 2020 (26.87%) and lowest in 2023 (13.04%).
How does Laboratorios Richmond S.A.C.I.F.'s operating margin compare with similar companies?
Laboratorios Richmond S.A.C.I.F.'s operating margin (17.67%) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.